Cancer Active
Navigation
 
Cancer Prevention Cancer Treatment Support Us Online Shop
Chris Woolmams
Can Cimetidine play a part in cancer cure?

Chris Woollams. CANCERactive. This article looks at a common over-the-counter medicine called Cimetidine, or Tagamet, and how research shows it seems to play an important role in stopping at least one aspect of the cancer process.

As regular readers know, I do not believe any single compound not Herceptin, not Temozolomide, not Vitamin D, not B-17 is a cancer ´cure´.

I believe cancer is a multi-step process and there are some very real ´treatments´ that can have a profound effect on particular steps: - Like Memorial Sloan-Kettering´s research showing resveratrol can stop COX-2 doing its inflammatory work in breast cancer; or Emory School of Medicine showing that curcumin stops vascular endothelial growth factors (making blood vessels for tumours), or Harvard Medical School showing vitamin D can convert cancer cells back to normal cells. These are but steps in the process that makes up a full-blown cancer.

One such step is the need for cancer cells to be sticky. The sticky ones survive in the blood stream by sticking to the blood vessel walls; they also use the stickiness to ´clump´ together with other cancer cells and start a tumour. The stickiness also holds the tumour together. The velcro-like stickiness is caused by E-selectin. Cimetidine is now known to block E-selectin.

Cimetidine, or Tagamet, is a cheap over-the-counted medicine which was approved by the FDA back in 1977. It is a histamine receptor antagonist, and is used to treat stomach and duodenal ulcers and heartburn and indigestion. Histamines cause the stomach to produce acid and cimetidine stops this.

Cimetidine works against histamine receptor sites on the cell wall. And histamines seem to be required to bind cancer cells together. Trials have been conducted on other ´histamine-receptor antagonists´ but to no avail.

The first report of cimetidine´s use with cancer was an article in The Lancet in 1979 (1: 882-883) which reported that it possessed anti-tumour abilities. It had been used with a lung cancer patient. Several studies with mice followed until another Lancet report showed it effective with melanoma patients, where it cleared up the ´ulceration´ of tumours.

A number of papers then appeared in the New England Journal of Medicine and The Lancet showing its effectiveness amongst patients after colorectal cancer operations, either used on its own or in conjunction with standard treatments. By 2002 the British Journal of Cancer reported a trial with 64 patients. The group without cimetidine showed a 10-year survival of 49.8, whereas the group also taking cimetidine had a 10-year survival of 84.6 per cent. In the group with the most aggressive cancers the figures were, without 23 per cent; with 85 per cent! The important conclusion was to give the drug before and during surgery.

This conclusion was reinforced by two studies one from Japan (Fujita Health University; Matsumoto; Lancet 1995; 346: 115) where the group taking cimetidine with the chemotherapy 5-FU had a 4-year survival of 96.3 per cent compared to the group on chemo only of 68.8 per cent. The cimetidine was given before the surgery. However, in a Danish study where it was started 3 weeks after surgery there was no benefit over the control group.

In our article, ´Can Surgery Spread Cancer?´ we looked at various ways in which surgery may cause more metastatic activity. Cimetidine may in fact help in two ways not just by its histamine-preventing activity stopping cells clumping together, but it just may boost the immune system as well.

In 1997 the journal Cancer (80: 15-21) reported a study by Adams and Morris where again the cimetidine was given before and during colorectal surgery. They looked at white blood lymphocytes before and after the surgery. Those patients taking the cimetidine showed an improvement in lymphocyte levels in more than half the subjects, whereas the placebo boosted the levels in under a quarter of the control group. Equally important was the follow up where 3-year survival was ´in line with the findings at the time of surgery´. It is possible that this immune response as an independent benefit. But it is equally possible that it exists because the immune system has less work to do in the cimetidine group as it stops the formation of, and breaks down the adherence in, tumours.

Other studies have looked at prostate cancer and found similar improved survival figures.

If you are having surgery you might be well advised to look into this cheap medicine and start using it in advance of the operation! It seems to be another excellent example of integrative, or holistic, cancer treatment in action. But tell your surgeon in advance and quote the research. He simply may not know!

You may also wish to read this article before you have surgery too. Click here.


Click here for more details.
Want the latest news on this?
Email:
Print This Page
 
  Search Website
 
table-top

The CANCERactive Patient Group (CAPG) – Run by Patients, for Patients

  • Tell your Story
  • Start a Blog
  • Start a Diary Blog
  • Start a Discussion
  • Ask a Question

Search Drugs
table-top

CANCER DRUGS

Quick search for YOUR DRUG here  

Search Drugs
table-top

COMPLEMENTARY THERAPIES

Quick search for a COMPLEMENTARY THERAPY here 

Search Complementary Therapies
table-top

ALTERNATIVE THERAPIES

Quick search an ALTERNATIVE CANCER TREATMENT here

Search Alternative Therapies
table-top



Important Notice

At CANCERactive we provide information that is already in the public domain.  It is not our intention to provide advice. It is up to the reader to decide if any of the matters to which any article refers might be suitable for them.

table-toptable-top
table-top



Follow CHRIS WOOLLAMS, the UK's number 1 cancer researcher, on his free e-news and keep right up to date with the very latest cancer information and research





 click here


  click here


table-top



CANCERactive information and publications (books, magazine and leaflets)

CANCERactive compiled books

The Brand new 4th edition of
Everything You Need to Know to Help You Beat Cancer



"This book is head and shoulders above the rest". Geoffrey Boycott

Click here to find out more.

The Rainbow Diet - and how it can help you beat cancer



"At last the definitive book on a diet to fight cancer". Mrs BS Devon.

 Click here to find out more...


Brand new 3rd edition of Oestrogen The Killer in our Midst



"Learn how to take control of your oestrogen levels"

 Click here to find out more...

CANCERactive magazine (free in hospitals and complementary cancer centres)

icon

Free downloadable prevention leaflets

Cancer




Buy online
table-top

Donate to Us

We can only help people like you - if people like you help us!

Buy online
table-top

Fund Raising

SKYDIVING/
PARACHUTING


Interested? Click here for more information


Click here to see all our fundraising events.


Click here and see what events are taking place and perhaps sponsor one of our supporters. 

Click here for other ways to raise money for CANCERactive.

Or if you want more information about our other fun activities, the Peru trek, our sky diving etc. click the button below.

Click here for our Just Giving page and see what our supporters are doing for us.

Buy online
table-top

Sign up for icon

 






Our 68 page icon magazine is available free in over 500 UK hospitals, cancer centres and libraries. Full of great articles and the very latest cancer information, you can have it sent to your own home.

Buy online
table-top

Visit a Catherine Corner

Catherine Wollams

Buy online
table-top

Need a Support Group?  

Find a cancer support group near you, now.
Buy online
table-top

So what is the truth behind mammograms, drug clinical trials, the PSA test and prostate surgery, and the stories you read in the press? Go to Junk Science to read the unbiased truth. Click Here.

table-top

Do you have a problem with our factual content?

If you have research which conflicts with ours, just address it to 'The Medical Board'. Ever since we started this site we have had an 'open-mind' policy and have expert oncology doctors and professors who will address your concerns.

 
© Copyright 2012 CANCERactive. All Rights Reserved. This content may be copied in full, with copyright, contact, creation and information intact, without specific permission, when used only in a not-for-profit format and provided, where used to publish on a website, that website provides a link to www.canceractive.com. If any other use is desired, permission in writing from CANCERactive is required.
All content and images © Copyright 2009 - Website design and maintenance by Dualmedia.co.uk a Web design and Search engine marketing company